Bevacizumab as a treatment option for choroidal neovascularisation due to large optic nerve drusen in a 14-year-old girl
Purpose: To report the effects of a single intravitreous injection of bevacizumab for the treatment of secondary choroideal neovascularisation due to large optic disc drusen.Methods: A 14-year-old female patient with painless loss of vision iye presented with unusually large optic disc drusen and jy...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
German Medical Science GMS Publishing House
2020-08-01
|
| Series: | GMS Ophthalmology Cases |
| Subjects: | |
| Online Access: | http://www.egms.de/static/en/journals/oc/2020-10/oc000160.shtml |
| Summary: | Purpose: To report the effects of a single intravitreous injection of bevacizumab for the treatment of secondary choroideal neovascularisation due to large optic disc drusen.Methods: A 14-year-old female patient with painless loss of vision iye presented with unusually large optic disc drusen and jy choroidal neovascularisation with subretinal hemorrhaghe was treated with a single intravitreous injection of bevacizumab.Results: Visual acuity increased from 20/100 to 20/25 within 4 weeks after injection and remained at this level during the 12-month follow-up period.Conclusions: Bevacizumab is a possible primary treatment option for secondary choroidal neovascularisation due to large optic disc drusen in children as an alternative to other more invasive or complex procedures. |
|---|---|
| ISSN: | 2193-1496 |